Vision screening standards for fitness to drive
1 December 2022
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
Big Data, driver vision standards, driving, electronic medical records, vision, visual acuity
Most countries require that vision meets a pre-defined standard in order to be legally permitted to drive, but these standards vary widely. The primary method by which vision is assessed to determine suitability for driving is by measuring visual acuity...
Practice patterns in managing exogenous endophthalmitis
1 December 2022
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
Global practice patterns, endophthalmitis, exogenous endophthalmitis, ophthalmology
The authors of this study conducted a global survey of medical institutions regarding management of exogenous endophthalmitis to assess current practice patterns for this sight-threatening emergency. Thirty-six (of 42 institutions) responded and were included in the analysis. Results were as...
Distribution, progression, and outcomes of inflammatory chorioretinal lesions
1 December 2022
| Kelvin Cheng
|
Retina / Uvea / Vitreous
|
Autofluorescence, inflammatory lesions, multifocal choroiditis, multimodal imaging, optical coherence tomography, punctate inner choroidopathy, uveitis
This study investigated the distribution and progression of multifocal choroiditis (MFC) inflammatory lesions in 25 eyes of 20 patients and their correlations with clinical outcomes at 24 months. The distribution of choroiditis inflammatory lesions were evaluated semi-automatically using a dedicated...
Diagnostic and prognostic roles of serum interleukin-6 in patients with uveitis
1 December 2022
| Kelvin Cheng
|
Retina / Uvea / Vitreous
|
Behçet’s disease, interleukin-6, juvenile idiopathic arthritis, rheumatoid arthritis, systemic lupus erythematosus, uveitis
This is a retrospective observational case series investigating the diagnostic and prognostic role of serum interleukin (IL)-6 in patients with uveitis involving 80 patients – 60 patients (75%) with normal IL-6 levels and 20 patients (25%) with high IL-6 levels....
Chorioretinal atrophy in punctate inner choroidopathy / multifocal choroiditis
1 December 2022
| Kelvin Cheng
|
Retina / Uvea / Vitreous
|
Chorioretinal atrophy, long-term outcome, multifocal choroiditis, punctate inner choroidopathy, white dots syndrome
This study reported the five-year outcomes of chorioretinal atrophy (CRA) progression in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) in 45 eyes of 36 patients. The mean age of the cohort of patients was 37 ±13.37 years...
Efficacy of combined vitrectomy with intravitreal corticosteroid injection for ERM
1 December 2022
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Dexamethasone, Epiretinal membrane, Intravitreal injection, Triamcinolone, Vitrectomy
In this study the authors evaluated the efficacy of vitrectomy combined with corticosteroid injection for idiopathic epiretinal membrane (ERM). A systematic literature review was conducted by searching three electronic databases, PubMed, Embase and Medline, up to 2020 for relevant studies....
Elevated risk of mood disorders after recurrent retinal detachment
1 December 2022
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Epidemiology, Gender, Major depression disorder, Mood disorder, Retinal detachment
This study was aimed to investigate the risk of mood disorders in patients who experienced retinal detachment (RD) by using the National Health Insurance Research Database in Taiwan. A total of 4129 participants diagnosed with RD and 16,516 non-RD individuals...
Aflibercept (AF) for age-related macular degeneration (ARMD): four-year outcomes of a ‘’treat-and-extend’ (T&E) regimen with exit-strategy
This is a retrospective observational study of 82 patients, between 2014 to 2016 from Switzerland of treatment-naive patients with nARMD, treated with AF, with specific T&E protocol without a loading phase and predefined exit criteria and patients were observed three...
Progression of macular atrophy on long-term anti-VEGF therapy for AMD
3 October 2022
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Anti-VEGF therapy, Long term, Macular atrophy, neovascular age-related macular degeneration
This retrospective study evaluated the progression of macular atrophy in 53 eyes of 53 patients receiving AntiVEGF Therapy for age-related macular degeneration (nAMD), for at least six years. None of the patients had any macular atrophy (MA) at presentation. MA...
Understanding retinal ciliopathy through Bardet-Biedl syndrome
5 August 2022
| Zhihang Cheng
|
Retina / Uvea / Vitreous
This is a review article looking at up-to-date understanding and ongoing research in retinal ciliopathies. Syndromic ciliopathies consist of a group of disorders caused by ciliary dysfunction or abnormal ciliogenesis. These disorders have multiorgan involvement in addition to retinal degeneration...
A to Z of X-linked retinopathies
5 August 2022
| Zhihang Cheng
|
Retina / Uvea / Vitreous
This review article provides an excellent summary of X-linked retinopathies and the corresponding genotype and clinical features. The authors provide a comprehensive overview of each condition in terms of its pathogenesis, clinical features, imaging findings, electrophysiology changes and any current...
Changes in the prevalence of myopia in middle-aged caucasian Australians compared to UK biobank
5 August 2022
| Ivan Yip
|
Retina / Uvea / Vitreous
This article compares rates of myopia and high myopia in large cohorts of caucasian Australians from the Busselton Healthy Ageing Study, the urban Gen1 of the Raine Study, the Blue Mountains Eye study and Melbourne Visual Impairment Project. The former...
